Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Jochen Klaus Maria Lennerz, Ph.D., M.D.

Co-Author

This page shows the publications co-authored by Jochen Lennerz and Valentina Nardi.
Connection Strength

2.604
  1. t(4;12)(q12;p13) ETV6-rearranged AML without eosinophilia does not involve PDGFRA: relevance for imatinib insensitivity. Blood Adv. 2021 Sep 29.
    View in: PubMed
    Score: 0.247
  2. Two In Cis Variants-Two Worlds Apart. Oncologist. 2021 Aug 18.
    View in: PubMed
    Score: 0.245
  3. Clinical sensitivity and interpretation of PCR and serological COVID-19 diagnostics for patients presenting to the hospital. FASEB J. 2020 10; 34(10):13877-13884.
    View in: PubMed
    Score: 0.229
  4. Targeted Informatics for Optimal Detection, Characterization, and Quantification of FLT3 Internal Tandem Duplications Across Multiple Next-Generation Sequencing Platforms. J Mol Diagn. 2020 09; 22(9):1162-1178.
    View in: PubMed
    Score: 0.227
  5. Novel and established EWSR1 gene fusions and associations identified by next-generation sequencing and fluorescence in-situ hybridization. Hum Pathol. 2019 11; 93:65-73.
    View in: PubMed
    Score: 0.214
  6. Financially effective test algorithm to identify an aggressive, EGFR-amplified variant of IDH-wildtype, lower-grade diffuse glioma. Neuro Oncol. 2019 05 06; 21(5):596-605.
    View in: PubMed
    Score: 0.209
  7. Clinically Integrated Molecular Diagnostics in Adenoid Cystic Carcinoma. Oncologist. 2019 10; 24(10):1356-1367.
    View in: PubMed
    Score: 0.208
  8. Clinicopathological and molecular features of SF3B1-mutated myeloproliferative neoplasms. Hum Pathol. 2019 04; 86:1-11.
    View in: PubMed
    Score: 0.204
  9. Clinical Utility of Rapid EGFR Genotyping in Advanced Lung Cancer. JCO Precis Oncol. 2018; 2018.
    View in: PubMed
    Score: 0.198
  10. Artificial Intelligence Approach for Variant Reporting. JCO Clin Cancer Inform. 2018; 2.
    View in: PubMed
    Score: 0.194
  11. MET Amplification in Esophageal Squamous Carcinoma. Int J Surg Pathol. 2018 12; 26(8):731-732.
    View in: PubMed
    Score: 0.194
  12. Clinical Utility of Anchored Multiplex Solid Fusion Assay for Diagnosis of Bone and Soft Tissue Tumors. Am J Surg Pathol. 2021 08 01; 45(8):1127-1137.
    View in: PubMed
    Score: 0.061
  13. Identification of EWSR1-NFATC2 fusion in simple bone cysts. Histopathology. 2021 May; 78(6):849-856.
    View in: PubMed
    Score: 0.060
  14. Mechanisms of resistance to selective RET tyrosine kinase inhibitors in RET fusion-positive non-small-cell lung cancer. Ann Oncol. 2020 12; 31(12):1725-1733.
    View in: PubMed
    Score: 0.058
  15. Pan-sarcoma genomic analysis of KMT2A rearrangements reveals distinct subtypes defined by YAP1-KMT2A-YAP1 and VIM-KMT2A fusions. Mod Pathol. 2020 11; 33(11):2307-2317.
    View in: PubMed
    Score: 0.056
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.